Login / Signup

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.

Hannah PeckhamNina M de GruijterCharles RaineAnna RadziszewskaCoziana CiurtinLucy R WedderburnElizabeth C RosserKate WebbClaire T Deakin
Published in: Nature communications (2020)
Anecdotal evidence suggests that Coronavirus disease 2019 (COVID-19), caused by the coronavirus SARS-CoV-2, exhibits differences in morbidity and mortality between sexes. Here, we present a meta-analysis of 3,111,714 reported global cases to demonstrate that, whilst there is no difference in the proportion of males and females with confirmed COVID-19, male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission (OR = 2.84; 95% CI = 2.06, 3.92) and higher odds of death (OR = 1.39; 95% CI = 1.31, 1.47) compared to females. With few exceptions, the sex bias observed in COVID-19 is a worldwide phenomenon. An appreciation of how sex is influencing COVID-19 outcomes will have important implications for clinical management and mitigation strategies for this disease.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • systematic review
  • emergency department
  • newly diagnosed
  • type diabetes
  • meta analyses
  • insulin resistance
  • combination therapy
  • replacement therapy